# Status

Updated: 2026-10-09T12:24:10Z

Current milestone: **M0 — Research and plan**, deliverables complete and **ready
for harness review**. No review or GATE exists yet. Work remains research only;
NEXT_ACTION requests REVIEW M0. Do not begin M1 until the harness closes M0.

## Acceptance status

- **All research/0x documents, synthesis and required ADRs: SATISFIED.** Seven
  research documents (`01`–`07`), source register, brief/glossary and
  docs/01-phase0-synthesis.md exist. Required ADR-001/002/003/004 and additional
  ADR-005 have Accepted (autopilot) — pending human review status; all queued.
  reviews/M0/HANDOFF.md maps deliverables, verification and five uncertainties.
- **Every dataset claim sourced or UNVERIFIED: SATISFIED.** Survey retains primary
  links and explicit uncertainty/access limits. No real dataset approved or
  acquired; ADR-002 remains synthetic-only. Research documents distinguish
  proposals from facts and end with Open questions and Confidence.
- **Review/gate: PENDING.** Only the harness runs review.sh, writes tests of record
  and closes GATE.md. No engineering, scientific or clinical approval claimed.

## Verification observed

- `python3 -m unittest discover -s tests -v`: all **5** tests passed after final
  handoff and source-register edits. Added citation-register coverage; existing
  checks cover ignored paths, no tracked data, local links and uncertainty sections.
  These do not verify research facts, legal compliance or clinical rule safety.
- `bash scripts/check.sh`: exit 0, RESULT PASS; ML and Android explicitly SKIPPED
  because projects do not exist. No APK or ML/clinical validation claimed.
- External citation coverage audit: no missing source-register URLs across builder
  research/docs/ADRs; permanent test now enforces this evidence bookkeeping.
- `git diff --check` and staged diff check passed. Research/handoff committed as
  29dc47b (M0: complete governance research and phase-zero handoff).
- No training/app implementation, photos, patient records, data archives, weights,
  toolchain installations, protected edits, review.sh, pushes or external messages.

## Decisions and open blockers

- ADR-004 selects local-only versioned consent/provenance records and explicit
  metadata export. Capture labels stay provisional; external clinical confirmation,
  steward-approved datasets and human model-release approval are separate events.
  No real collection, backend, research image transfer or automatic learning.
- Nepal custodian, credentials, consent/assent translations, numeric real-data
  retention, withdrawal/recipient-copy/model limits, residency and benefits need
  human institutional decisions before real collection. All queued in HUMAN-QUEUE.
- Full NHRC 2022 guidance opens failed on eLibrary and NHRC copies; DDA catalogue,
  record and directive opens failed. **Labelled research workaround:** indexed
  official evidence, plus an institution's IRC scope statement. Current review
  jurisdiction/application details and Numbra software classification UNVERIFIED.
- Government-linked English Privacy Act text inspected. Current amendments/rules,
  actor-specific duties, secondary-use, retention/breach/transfer interpretation
  remain UNVERIFIED; no clearance asserted. FDA/EU comparisons are illustrative.
- Existing dataset/clinical/current-burden/device/HMIS limitations remain in
  research/HANDOFF/HUMAN-QUEUE. Proposed thresholds, letterbox, parity tolerance
  and device budgets are unvalidated engineering choices. Every downstream model,
  report and app inference surface must say **PLACEHOLDER**.
- Firecrawl still has zero credits; retained the previously documented web-tool
  workaround with no auth/account/billing changes. No blocker to bounded M0 review.

## Next concrete step

Harness reviews M0. On the next iteration, read its REVIEW and CHECK in full;
without a gate answer every numbered issue in RESPONSE and revise the research.
If a gate exists, fix cheap non-blocking issues, queue the rest and begin **M1 only**:
pinned Python project, taxonomy/manifest/loading interfaces and generated synthetic
fixture tests. Scientific, clinical and legal field-use approvals remain separate.
